Publications by authors named "Peter J Colman"

Claim this Profile
R
Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles.
Chris Chamberlain, Peter J Colman, Ann M Ranger, Linda C Burkly, Geoffrey I Johnston

Ann Rheum Disยท November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis